By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

PTC Therapeutics, Inc. 

100 Corporate Court

South Plainfield  New Jersey  07080-2449  U.S.A.
Phone: 908-222-7000 Fax: 908-222-7231


SEARCH JOBS



Segment
Drug Discovery





Company News
PTC Therapeutics (PTCT) Reports Fourth Quarter And 2014 Full Year Financial Results And Provides Corporate Update 2/27/2015 9:38:57 AM
PTC Therapeutics, Inc. (PTCT) To Participate At Upcoming March Investor Conferences 2/16/2015 11:43:43 AM
PTC Therapeutics, Inc. (PTCT) To Host Conference Call To Discuss Fourth Quarter And Year End 2014 Financial Results 2/16/2015 11:23:36 AM
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 2/9/2015 7:46:46 AM
PTC Therapeutics, Inc. (PTCT) To Participate At Upcoming Investor Conferences 2/6/2015 7:45:46 AM
PTC Therapeutics, Inc. (PTCT) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/7/2015 8:58:07 AM
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 1/5/2015 8:13:20 AM
PTC Therapeutics, Inc. (PTCT) Begins Rolling NDA Submission To The FDA For Translarna To Treat Duchenne Muscular Dystrophy 12/23/2014 7:57:36 AM
PTC Therapeutics, Inc. (PTCT) Release: Translarna Granted Orphan Drug Designation In The U.S. And Europe For The Treatment Of Mucopolysaccharidosis I 12/19/2014 8:03:40 AM
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 12/18/2014 7:44:02 AM
12345678910...
//-->